Tofacitinib: a new oral Janus kinase inhibitor for psoriasis

被引：1
|
作者：
Gimenez-Arnau, A. M. [1 ]
机构：
[1] Univ Autonoma Barcelona, Hosp del Mar, Dept Dermatol, IMIM, Barcelona, Spain
来源：
BRITISH JOURNAL OF DERMATOLOGY | 2019年 / 180卷 / 01期
关键词：
HERPES-ZOSTER; EFFICACY; MODERATE; VACCINE;
D O I：
10.1111/bjd.17323
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
引用
收藏
页码：13 / 14
页数：2
相关论文
共 50 条
  • [1] Tofacitinib, an Oral Janus Kinase Inhibitor: Perspectives in Dermatology
    Kostovic, Kresimir
    Gulin, Sandra J.
    Mokos, Zrinka B.
    Ceovic, Romana
    CURRENT MEDICINAL CHEMISTRY, 2017, 24 (11) : 1158 - 1167
  • [2] Long-term safety data for tofacitinib, an oral Janus kinase inhibitor, for the treatment for psoriasis
    Lloyd-Lavery, A.
    BRITISH JOURNAL OF DERMATOLOGY, 2018, 179 (04) : 815 - 816
  • [3] Efficacy of topical tofacitinib, a Janus kinase inhibitor, in the treatment of plaque psoriasis
    Bagherani, Nooshin
    Smoller, Bruce R.
    DERMATOLOGIC THERAPY, 2017, 30 (03)
  • [4] Antipruritic Effects of Janus Kinase Inhibitor Tofacitinib in a Mouse Model of Psoriasis
    Hashimoto, Takashi
    Sakai, Kent
    Sanders, Kristen M.
    Yosipovitch, Gil
    Akiyama, Tasuku
    ACTA DERMATO-VENEREOLOGICA, 2019, 99 (03) : 298 - 303
  • [5] Tofacitinib, an Oral Janus Kinase Inhibitor, in Active Ulcerative Colitis
    Sandborn, William J.
    Ghosh, Subrata
    Panes, Julian
    Vranic, Ivana
    Su, Chinyu
    Rousell, Samantha
    Niezychowski, Wojciech
    NEW ENGLAND JOURNAL OF MEDICINE, 2012, 367 (07): : 616 - 624
  • [6] Tofacitinib: A novel oral Janus kinase inhibitor for rheumatoid arthritis
    O'Dell, Kate M.
    Rummel, Ashley E.
    FORMULARY, 2012, 47 (10) : 350 - +
  • [7] The Janus-Kinase-Inhibitor Tofacitinib
    Krome, Susanne
    ZEITSCHRIFT FUR GASTROENTEROLOGIE, 2013, 51 (01): : 7 - 7
  • [8] Tofacitinib, the First Oral Janus Kinase Inhibitor Approved for Adult Ulcerative Colitis
    Palasik, Brittany N.
    Wang, Hongmei
    JOURNAL OF PHARMACY PRACTICE, 2021, 34 (06) : 913 - 921
  • [9] The mechanism of action of tofacitinib - an oral Janus kinase inhibitor for the treatment of rheumatoid arthritis
    Hodge, J. A.
    Kawabata, T. T.
    Krishnaswami, S.
    Clark, J. D.
    Telliez, J. -B.
    Dowty, M. E.
    Menon, S.
    Lamba, M.
    Zwillich, S.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2016, 34 (02) : 318 - 328
  • [10] Treatment of recalcitrant atopic dermatitis with the oral Janus kinase inhibitor tofacitinib citrate
    Levy, Lauren L.
    Urban, Jennifer
    King, Brett A.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2015, 73 (03) : 395 - 399
12345